5 citations
,
January 2012 in “Dermatology” Adapted classification better assesses male pattern hair loss and its link to heart disease.
38 citations
,
February 2009 in “Journal of The European Academy of Dermatology and Venereology” Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.
21 citations
,
October 2023 in “Journal of Dermatological Treatment” Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.
November 2023 in “Cermin Dunia Kedokteran” Tinea capitis can affect mental health, but treatment improves both health and well-being.
112 citations
,
August 2012 in “The American Journal of Human Genetics” Mutations in the RBPJ gene cause Adams-Oliver Syndrome.
Interest in JAK inhibitors for hair loss increased significantly after media coverage and FDA approval.
18 citations
,
July 2015 in “Drug Healthcare and Patient Safety” Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.
51 citations
,
October 2019 in “Cells” Baricitinib reduces inflammation and improves cell health in premature aging cells.
4 citations
,
September 2015 in “Case Reports” A man fainted and felt unwell after using a strong hair growth product, but got better when he stopped using it.
December 2015 in “PLOS Genetics” November 2025 in “Skin Appendage Disorders” Androgenetic alopecia doesn't increase the risk of heart-related health issues.
September 2025 in “Australasian Journal of Dermatology” New medications could improve treatment for severe alopecia areata in Australia.
3 citations
,
April 2016 in “Journal of Investigative Dermatology” Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.
September 2024 in “Journal of the American Academy of Dermatology” Alopecia areata patients have a higher risk of blood clots.
January 2021 in “Research Portal Denmark” Tofacitinib helped a man with alopecia totalis regrow all his hair.
July 2017 in “Clin-Alert” Different medications can cause serious side effects in some people.
December 2023 in “Journal of dermatology” Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.
Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.
3 citations
,
January 2018 in “Skin Appendage Disorders” Nail issues are common in alopecia areata patients.
February 2004 in “Frontiers in Ecology and the Environment” Eating too much fish can lead to mercury poisoning.
May 2026 in “Journal of the American Academy of Dermatology” Early hair loss might indicate diabetes and heart risks, especially in those under 45.
19 citations
,
July 2018 in “Medicines” Juniperus plants contain compounds with potential for developing various medical treatments.
1 citations
,
January 2011 Thorough evaluation and lab tests are crucial for understanding hair loss causes.
January 2025 in “Digital Repository (National Repository of Grey Literature)” Red hair is linked to worse health, especially in women.
3 citations
,
May 2022 in “Pediatric Critical Care Medicine” The patient recovered well and returned to college without any lasting issues.
42 citations
,
April 2021 in “Journal of clinical pharmacology” Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.
2 citations
,
August 2025 in “Harm Reduction Journal” Non-medical steroid use in gym-goers is risky and needs better prevention and care strategies.
A few users dominate Reddit discussions on JAK inhibitors, highlighting social media's potential for tracking drug safety but needing expert oversight.
August 2017 in “International journal of Ayurvedic and herbal medicine” Bhallataka is a poisonous plant that, when detoxified, may have medicinal benefits for various health issues.